| Title | Expert Opinion on Pharmacotherapy |
| Abbreviation | Expert Opin. Pharmacother. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2) |
| h-index | 99 |
| Overall Rank/Ranking | 8507 |
| SCImago Journal Rank (SJR) | 0.672 |
| Impact Score | 2.21 |
| Publisher | Taylor and Francis Ltd. |
| Country | United Kingdom |
| ISSN | 17447666, 14656566 |
| Best Quartile | Q2 |
| Coverage History | 1999-2025 |
Expert Opinion on Pharmacotherapy ranks #123 of 216 in the Pharmacology & Pharmacy category in the 2008 ISI Journal Citation Reports.
Expert Opinion on Pharmacotherapy (ISSN 1465-6566 [print], 1744-7666 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on newly approved/near to launch compounds, providing expert opinion on the likely impact of these new agents on existing pharmacotherapy of specific diseases.
Expert Opinion on Pharmacotherapy is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2). It is published by Taylor and Francis Ltd.. The overall rank of Expert Opinion on Pharmacotherapy is 8507. According to SCImago Journal Rank (SJR), this journal is ranked 0.672. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 99. The best quartile for this journal is Q2.
The ISSN of Expert Opinion on Pharmacotherapy journal is 17447666, 14656566. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Expert Opinion on Pharmacotherapy is cited by a total of 1443 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Expert Opinion on Pharmacotherapy is 2.21, which is computed in 2025 as per its definition. Expert Opinion on Pharmacotherapy IF is increased by a factor of 0.06 and approximate percentage change is 2.79% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Expert Opinion on Pharmacotherapy is 2.21. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.21 |
| 2023 | 2.15 |
| 2022 | 2.62 |
| 2021 | 3.32 |
| 2020 | 2.86 |
| 2019 | 2.67 |
| 2018 | 2.78 |
| 2017 | 3.10 |
| 2016 | 3.39 |
| 2015 | 3.13 |
| 2014 | 2.90 |
Expert Opinion on Pharmacotherapy has an h-index of 99. It means 99 articles of this journal have more than 99 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Expert Opinion on Pharmacotherapy is 17447666, 14656566. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Expert Opinion on Pharmacotherapy is 8507. According to SCImago Journal Rank (SJR), this journal is ranked 0.672. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.672 |
| 2023 | 0.687 |
| 2022 | 0.702 |
| 2021 | 0.735 |
| 2020 | 0.873 |
| 2019 | 0.742 |
| 2018 | 0.866 |
| 2017 | 0.909 |
| 2016 | 1.014 |
| 2015 | 0.907 |
| 2014 | 0.764 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 8507 |
| 2023 | 7652 |
| 2022 | 7080 |
| 2021 | 6424 |
| 2020 | 5341 |
| 2019 | 6500 |
| 2018 | 5319 |
| 2017 | 4981 |
| 2016 | 4343 |
| 2015 | 5045 |
| 2014 | 6036 |
Expert Opinion on Pharmacotherapy is published by Taylor and Francis Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1999-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Expert Opinion on Pharmacotherapy is Expert Opin. Pharmacother.. This abbreviation ('Expert Opin. Pharmacother.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Expert Opinion on Pharmacotherapy latest impact IF is 2.21. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 3.39 (2016) and 2.15 (2023), respectively, in the last 11 years. Moreover, its average IS is 2.83 in the previous 11 years.
The Expert Opinion on Pharmacotherapy has an SJR (SCImago Journal Rank) of 0.672, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.014 in 2016 and the lowest being 0.672 in 2024. Furthermore, the average SJR of the Expert Opinion on Pharmacotherapy over the previous 11-year period stands at 2.83.
The latest h-index of the Expert Opinion on Pharmacotherapy is 99.
The Expert Opinion on Pharmacotherapy is published by the Taylor and Francis Ltd., with its country of publication being the United Kingdom.
The Expert Opinion on Pharmacotherapy is currently ranked 8507 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 4343 in 2016 and its lowest position of 8507 in 2024.
The standard ISO4 abbreviation for the Expert Opinion on Pharmacotherapy is Expert Opin. Pharmacother..
Expert Opinion on Pharmacotherapy is classified as a journal that the Taylor and Francis Ltd. publishes.
The Expert Opinion on Pharmacotherapy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Expert Opinion on Pharmacotherapy is assigned the following International Standard Serial Numbers (ISSN): 17447666, 14656566.
The best quartile for the Expert Opinion on Pharmacotherapy is Q2 (2024).
The Expert Opinion on Pharmacotherapy coverage history can be summarized as follows: 1999-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Academic Ethics | journal | 8704 | Springer Netherlands | 34 | 4.04 |
| Zeitschrift fur Germanistische Linguistik | journal | 27452 | Walter de Gruyter GmbH | 17 | 0.29 |
| Applied Ecology and Environmental Research | journal | 19122 | Corvinus University of Budapest | 48 | 0.84 |
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Journal of Applied Business Research | journal | 26260 | Clute Institute | 33 | 0.17 |
| Entrepreneurship Theory and Practice | journal | 168 | SAGE Publications Ltd | 212 | 13.35 |
| Journal, Indian Academy of Clinical Medicine | journal | 28559 | Indian Academy of Clinical Medicine | 16 | 0.10 |
| European Journal of Education | journal | 4974 | Wiley-Blackwell Publishing Ltd | 63 | 5.08 |
| Sex Education | journal | 6348 | Routledge | 51 | 2.49 |
| Transnational Corporations | journal | 13970 | UNCTAD United Nations Conference on Trade and Development | 30 | 1.63 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.21 |
| 2023 | 2.15 |
| 2022 | 2.62 |
| 2021 | 3.32 |
| 2020 | 2.86 |
| 2019 | 2.67 |
| 2018 | 2.78 |
| 2017 | 3.10 |
| 2016 | 3.39 |
| 2015 | 3.13 |
| 2014 | 2.90 |
